Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Blood Cancer
Cancer
Bristol Myers Squibb
Cancer Treatment
Leukaemia
Lung Cancer
Ovarian Cancer
Topics

Advertisement

Blood Cancer

Share

Top Latest Popular

⚽ PREMIER DEAL! Follow the action with NewsNow Essentials at just £2.99/m!

⚽ PREMIER DEAL! Follow the action with NewsNow Essentials at just £2.99 a month!

'Out of options': Cancer patient seeks $200k treatment in China New Zealand Herald 4d

New Zealand Herald 4d

ASCO26: Blood cancer readouts take centre stage Clinical Trials Arena 7d

Clinical Trials Arena 7d

Celmod drug cuts risk of myeloma progression, death by 52% in trial Medpage Today 8d

Medpage Today 8d

Advertisement

Discussing emerging therapies and shared decision-Making in multiple myeloma Medpage Today 8d

Medpage Today 8d

Advertisement

ASCO26: BMS and J&J debut shining multiple myeloma data Clinical Trials Arena 12:11 Mon, 01 Jun

Clinical Trials Arena 12:11 Mon, 01 Jun

Mezigdomide shows survival benefit in RRMM Hematology Advisor 23:06 Sat, 30 May

Hematology Advisor 23:06 Sat, 30 May

Advertisement

Advertisement

Latest

In the last 2 hours

MajesTEC-9: Teclistamab Monotherapy Improves Survival in RRMM Hematology Advisor 17:13

In the last 4 hours

PRIMO Trial Demonstrates Promising Duvelisib Activity in PTCL Hematology Advisor 15:10

Tafasitamab Combination Regimen Bests R-CHOP Alone in High-Risk DLBCL Hematology Advisor 15:10

ASCO: Teclistamab Improves Survival in Relapsed, Refractory Multiple Myeloma Hematology Advisor 15:10

Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma PharmaTimes 15:02

In the last 8 hours

Ex-North End footballer spreads awareness of incurable myeloma Lancashire Evening Post 12:08

Earlier Today

J&J secures extended NICE approval for Darzalex following earlier refusal Pharmaceutical Technology 09:48

Yesterday

Case Report: Patient With MG Develops Mycophenolate-Induced EBV-Positive PCNSL Rare Disease Advisor 23:56 Mon, 08 Jun

Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics Pharmaceutical Technology 17:51 Mon, 08 Jun

AbbVie Presents New Data Across Its Blood Cancer Portfolio at EHA 2026 AbbVie (Press Release) 13:01 Mon, 08 Jun

Advertisement

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
- Cancer Cancer
  Back to Health Cancer
  - Blood Cancer
  - Breast Cancer
  - Cancer Research
  - Cancer Treatment
  - CAR-T CAR-T
  - Cervical Cancer
  - Cervical Screening
  - Colorectal Cancer
  - HPV HPV
  - Leukaemia Leukaemia
  - Lung Cancer
  - Ovarian Cancer
  - Prostate Cancer